Please use this identifier to cite or link to this item:
Title: Risk factors for development of acute necrotizing pancreatitis
Authors: Stojanovic B.
Spasic M.
Radosavljevic, Ivan
Canovic D.
Radovanovic D.
Praznik I.
Prodanovic, Nikola
Milojević A.
Jelic I.
Babic Z.
Artinović V.
Grubor I.
Nikolic L.
Vucicevic, Ksenija
Miljkovic J.
Divjak, Ana
Stefanovic, Srdjan
Jankovic, Slobodan
Journal: Serbian Journal of Experimental and Clinical Research
Issue Date: 1-Jan-2015
Abstract: © 2015 University of Kragujevac, Faculty of Science. All rights reserved. Acute necrotizing pancreatitis (ANP) is a severe form of acute pancreatitis that is associated with high morbidity and mortality. Thus, an adequate initial treatment of patients who present with acute pancreatitis (AP) based on correct interpretation of early detected laboratory and clinical abnormalities may have a signifi cant positive impact on the disease course. T e aim of the study was to determine patient- and initial treatment- related risk factors for the development of acute necrotizing pancreatitis. For the purpose of this study a case-control design was chosen, including adult patients treated for AP in the surgical Intensive Care Unit (sICU) of Clinical Center of Kraguje-vac, from January 2006 to January 2011. The cases (n=63) were patients who developed ANP, while the controls (n=63) were patients with AP without the presence of pancreatic necrosis. The controls were randomly selected from a study sample after matching with the cases by age and sex. Signifi cant association with the development of ANP was found for the presence of comorbidity (adjusted OR 6.614 95%CI 1.185-36.963), and the use of somatostatin (adjusted OR 7.460, 95%CI 1.162-47.833) and furosemide (adjusted OR 2710.57, 95%CI 1.996- 56.035) started immediately upon admission to the sICU. T is study suggests that comorbidities, particularly the presence of serious cardio-vascular disease, can increase the risk for development of acute necrotizing pancreatitis. The probability for the development of ANP could be reduced by the avoidance of the initial use of loop diuretics and somatostatin.
Type: Article
DOI: 10.1515/SJECR-2015-0016
ISSN: 18208665
SCOPUS: 84932644047
Appears in Collections:Faculty of Medical Sciences, Kragujevac
[ Google Scholar ]

Page views(s)


Files in This Item:
File Description SizeFormat 
10.1515-SJECR-2015-0016.pdf620.16 kBAdobe PDFThumbnail

Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.